Abstract Submissions

G-I-N conferences are a unique venue for worldwide sharing of knowledge about guideline development, dissemination, adaptation and implementation. Seize the opportunity and be a part of the G-I-N 2012 programme by submitting your original abstracts! The Scientific Committee aims to ensure that the diversity of the international audience is represented across all sessions. Submissions from all over the world are encouraged. In addition, submissions addressing collaboration on an international level, in different cultural regions, under different conditions and in multiprofessional teams are appreciated. Submissions on scientific research and innovative approaches and products are encouraged.

The G-I-N 2012 abstract submission system is now closed

This year G-I-N has received a record number of abstracts – over 400 submissions across 44 countries.

Submitted Abstracts

* We recommend that you use Internet Explorer to access the abstract submissions system

Abstracts can be submitted for:

Interactive Workshop (1,5 hour)
Parallel Panel Sessions (1,5 hour)
Short Oral Presentations (15 minute presentation + 5 minute discussion) - scientific presentation and/or best practice, successful programme
Posters - scientific presentation and/or best practice, successful programme

For the abstract to be reviewed favourably it must contain results, and should be formatted to include specific sections.
Click HERE for more information on abstract formatting.

Accepted abstracts will be published in GMS German Medical Science, an open access e-journal*. Additionally, a prize for the best poster will be awarded.
*By submitting an abstract, you agree that the text of your abstract along with your name and affiliation will be published on the conference website and in e-GMS and that this will not raise any copyright issues. In particular, you declare that the submitted content is your own intellectual property, i.e. it does not violate third parties' copyright, and that it has not been published elsewhere previously in this form. If you have any issues with consenting to this, please contact gin2012abstracts@conferencepartners.ie

Abstract submitters are requested to select their preferred presentation type and the relevant track for their abstract. Tracks are listed below.

Submissions on scientific research and innovative approaches and products are encouraged.

Important Dates
Deadline for Abstract Submissions	Midnight 14 February 2012
Notification of Acceptance of Abstracts	1 April 2012
End of Early Registration	30 April 2012
Conference	22 - 25 August 2012

Abstract Submission Tracks

1. Evidence Generation and Synthesis

101. Comparative and cost effectiveness research
102. Health technology assessment and guidelines
103. Identifying, appraising, and sharing evidence for guidelines
104. Qualitative research and single case studies
105. Quality assessment, assessment of the risk of bias
106. Synthesizing evidence (e.g., meta-analysis, decision modelling)
107. Other evidence generation and synthesis

2. Guideline Development

201. Accrediting guideline developers
202. Appraising and updating guidelines
203. Challenges of cultural and linguistic diversity
204. New 2012: Consensus development methodology
205. New 2012: Developing guidelines for diagnostic test accuracy questions
206. Equity in guidelines
207. New 2012: Ethical issues, values and preference integration in guidelines
208. Funding guideline development
209. Grading, including qualitative studies
210. Guidelines for policy and health systems strengthening
211. Harms, adverse events, and patient safety
212. Incorporating resources/cost considerations/economic evaluation into guidelines
213. New 2012: International guidelines and cooperations
214. Managing conflicts of interest
215. Methodology, skills, and resources
216. New 2012: Patient involvement methodology
217. New 2012: Patients with specific needs (e.g. gender, age, co-morbidity)
218. New 2012: Prioritisation of topics -how many guidelines do we need?
219. Tailoring guideline recommendations to individual patients
220. Other guideline development

3. Stakeholders and Dissemination

301. Adapting guidelines and sharing work locally and internationally
302. Applicability assessment in guideline adaptation
303. Capacity building in guideline adaptation
304. Consumers, patients, and families
305. Guideline panels, groups, development committees
306. New 2012: National Guideline Programmes: experiences from governmental and non-governmental organisations
307. Publishing guidelines and guideline libraries
308. Resource-constrained settings and countries
309. Other stakeholders and dissemination

4. Guideline Implementation

401. Barriers to implementation
402. Change management
403. Computer-based decision support and e-tools
404. Development and implementation of guideline-based performance measures
405. New 2012: Guideline implementation in different countries/regions
406. Guidelines and the law
407. New 2012: Guidelines in the context of quality improvement initiatives: national and international collaborations (e.g. benchmarking, accreditation, p4p)
408. Incorporating guidelines into healthcare policy, practice and systems
409. Incorporating guidelines into medical education
410. New 2012: Patient decision aids and guidelines
411. Uptake, impact and outcomes of guidelines
412. Other guideline implementation

Please note that the Scientific Committee reserves the right to move topics into other tracks if they deem them to be more appropriate or to combine them with other related presentations. When accepting an abstract for presentation, the Scientific Committee also reserves the right to modify the type of presentation preferred by the submitter to ensure overall coherence of the programme.